Back

Immune checkpoint inhibitors and cardiovascular events, real world data from Belgium

19 June 2026 (14:15 - 15:15)
Organised by: Logo
Congress Presentation Part of: Immune-mediated cardiovascular toxicity: from early detection to real-world evidence Diagnosis and Management of Cardiovascular Disease in Patients with Cancer CCO Premium Access ESC Cardio-Oncology 2026 Council of Cardio-Oncology

About the speaker

Photo
Mrs Camille Blanchaert

University Hospital Antwerp, Edegem (Belgium)

9 More presentations in this session

Presentation thumbnail
Clinical significance of early asymptomatic high-sensitivity troponin T elevation in patients receiving immune checkpoint inhibitors
Doctor M. Akagi (Kumamoto, JP)
Abstract Slides
Presentation thumbnail
Early subclinical myocardial, vascular and endothelial dysfunction in cancer patients treated with immune checkpoint inhibitors
Doctor E. Karamanolis (Athens, GR)
Abstract Slides
Presentation thumbnail
Glucocorticoid resistant ICI associated myocarditis is defined by an interferon gamma driven myeloid inflammatory signature
Doctor J. Brauer (Heidelberg, DE)
Abstract Slides
Presentation thumbnail
Cardiac troponin identifies immune checkpoint inhibitor associated myocarditis and stratifies cardiovascular risk a systematic review and meta analysis
Mr A. Alfehaid (KW)
Abstract Slides
Presentation thumbnail
Cardiac rhythm disorders as cardiovascular toxicity of immune checkpoint inhibitors therapy: incidence and prognostic value
Doctor D. Vlachopoulou (Essen, DE)
Abstract Slides

Access the full session

Session thumbnail
Immune-mediated cardiovascular toxicity: from early detection to real-world evidence

The Event

Event poster

ESC Cardio-Oncology 2026

19 June 2026 14:15 CET
You may be interested in
thumbnail
Congress Presentation
Immune-related cardiovascular adverse events in a real-world cohort of patients treated with immune checkpoint inhibitors
20 June 2025
thumbnail
Congress Presentation
Immune checkpoint inhibition increases aortic inflammation on 18F-FDG PET/CT: a retrospective cohort study in patients with Merkel cell carcinoma receiving avelumab
21 June 2025
thumbnail
Congress Presentation
The prognostic value of sodium-glucose co-transporter-2 inhibitors therapy among patients with cancer and diabetes mellitus, treated with immune checkpoint inhibitors
21 May 2023
thumbnail
Congress Session
Cardiovascular disease management in patients with cancer
31 August 2024

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources